Table 3. Estimated TMB of the 30 NSCLC patients from the small and large gene panels.

Patient ID	MaxAF (LungCore)	Mutation count (LungCore)	TMB LungCore	TMB OncoScreen
F21510*	61.31%	19	77.6	90.5
F21511*	13.27%	12	49.0	39.7
F21501*	79.46%	11	44.9	68.3
F21492*	76.35%	11	44.9	51.6
F21508*	61.90%	10	40.8	49.2
F21514*	57.33%	9	36.7	20.6
F21516*	35.58%	9	36.7	20.6
F21503*	57.91%	9	36.7	16.7
F21498*	48.62%	8	32.7	11.1
F21496*	35.28%	7	28.6	34.9
F21515*	91.69%	7	28.6	26.2
F21502*	80.71%	6	24.5	29.4
F21504*	14.76%	6	24.5	20.6
F21495*	35.66%	6	24.5	17.5
F21505*	23.57%	6	24.5	15.9
F21493*	19.28%	6	24.5	11.1
F21499*	81.11%	5	20.4	23.0
F21513*	65.59%	5	20.4	12.7
F21506*	67.28%	5	20.4	11.9
F21497*	45.69%	5	20.4	11.1
F45309*	56.47%	4	16.3	12.7
F45303	55.60%	4	16.3	5.6
F45305*	86.63%	3	12.2	17.5
F45308	44.86%	3	12.2	4.8
F45304	54.78%	2	8.2	4.0
F45307	71.28%	2	8.2	5.6
F45298	38.30%	1	4.1	10.3
F45299	92.37%	1	4.1	4.8
F45300	31.24%	1	4.1	2.4
F45302	44.65%	0	0	5.6

Patient data with * indicate the patients whose actual TMB data from the small panel matches the actual TMB data from the 520-gene panel according to the cutoff of 10 mutations/Mb. NSCLC, non-small cell lung cancer; TMB, tumor mutation burden.